BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30824387)

  • 21. Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration.
    Papadopoulos A; Ribera A; Mavrogenis AF; Rodriguez-Pardo D; Bonnet E; Salles MJ; Dolores Del Toro M; Nguyen S; Blanco-García A; Skaliczki G; Soriano A; Benito N; Petersdorf S; Pasticci MB; Tattevin P; Tufan ZK; Chan M; O'Connell N; Pantazis N; Kyprianou A; Pigrau C; Megaloikonomos PD; Senneville E; Ariza J; Papagelopoulos PJ; Giannitsioti E;
    Int J Antimicrob Agents; 2019 Mar; 53(3):294-301. PubMed ID: 30395988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy.
    Crusio R; Rao S; Changawala N; Paul V; Tiu C; van Ginkel J; Chapnick E; Kupfer Y
    Scand J Infect Dis; 2014 Jan; 46(1):1-8. PubMed ID: 24206450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients.
    Falagas ME; Rafailidis PI; Ioannidou E; Alexiou VG; Matthaiou DK; Karageorgopoulos DE; Kapaskelis A; Nikita D; Michalopoulos A
    Int J Antimicrob Agents; 2010 Feb; 35(2):194-9. PubMed ID: 20006471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study.
    Zilberberg MD; Shorr AF; Micek ST; Vazquez-Guillamet C; Kollef MH
    Crit Care; 2014 Nov; 18(6):596. PubMed ID: 25412897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
    PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is colistin effective in the treatment of infections caused by multidrug-resistant (MDR) or extremely drug-resistant (XDR) gram-negative microorganisms in children?
    Ozsurekci Y; Aykac K; Cengiz AB; Bayhan C; Sancak B; Karadag Oncel E; Kara A; Ceyhan M
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):233-8. PubMed ID: 27041107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical profile and outcomes of adult patients given intravenous colistin for multidrug-resistant gram negative infections in a Philippine tertiary hospital.
    Li KL; Abad CLR
    Int J Infect Dis; 2020 Apr; 93():9-14. PubMed ID: 31978579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of mortality in bloodstream infections caused by multidrug-resistant gram-negative bacteria: 4 years of collection.
    Wang W; Jiang T; Zhang W; Li C; Chen J; Xiang D; Cao K; Qi LW; Li P; Zhu W; Chen W; Chen Y
    Am J Infect Control; 2017 Jan; 45(1):59-64. PubMed ID: 27765296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surveillance of resistance in the intensive care units using a cumulative antibiogram].
    Yürüyen C; Daldaban Dinçer Ş; Yanılmaz Ö; Boz ES; Aksaray S
    Mikrobiyol Bul; 2018 Oct; 52(4):329-339. PubMed ID: 30522419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients.
    Kontopidou F; Plachouras D; Papadomichelakis E; Koukos G; Galani I; Poulakou G; Dimopoulos G; Antoniadou A; Armaganidis A; Giamarellou H
    Clin Microbiol Infect; 2011 Nov; 17(11):E9-E11. PubMed ID: 21939468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance study.
    Lanini S; Costa AN; Puro V; Procaccio F; Grossi PA; Vespasiano F; Ricci A; Vesconi S; Ison MG; Carmeli Y; Ippolito G;
    PLoS One; 2015; 10(4):e0123706. PubMed ID: 25835018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Microbiological Outcomes in Obese Patients Receiving Colistin for Carbapenem-Resistant Gram-Negative Bloodstream Infection.
    Lam SW; Athans V
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment pattern, prognostic factors, and outcome in patients with infection due to pan-drug-resistant gram-negative bacteria.
    Kofteridis DP; Andrianaki AM; Maraki S; Mathioudaki A; Plataki M; Alexopoulou C; Ioannou P; Samonis G; Valachis A
    Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):965-970. PubMed ID: 31933017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsis.
    Micek S; Johnson MT; Reichley R; Kollef MH
    BMC Infect Dis; 2012 Mar; 12():56. PubMed ID: 22414209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extensively drug-resistant and pandrug-resistant Gram-negative bacteria in a tertiary-care hospital in Eastern India: A 4-year retrospective study.
    Mohapatra DP; Debata NK; Singh SK
    J Glob Antimicrob Resist; 2018 Dec; 15():246-249. PubMed ID: 30144638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical epidemiology of carbapenem-resistant gram-negative sepsis among hospitalized patients: Shifting burden of disease?
    Britt NS; Ritchie DJ; Kollef MH; Burnham CD; Durkin MJ; Hampton NB; Micek ST
    Am J Infect Control; 2018 Oct; 46(10):1092-1096. PubMed ID: 29706365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection.
    Micek ST; Hampton N; Kollef M
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug-resistant gram-negative bacterial infections in a teaching hospital in Ghana.
    Agyepong N; Govinden U; Owusu-Ofori A; Essack SY
    Antimicrob Resist Infect Control; 2018; 7():37. PubMed ID: 29541448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct medical costs of urinary tract infections by Gram-negative bacilli resistant to beta-lactams in a tertiary care hospital in Medellín, Colombia.
    Vargas-Alzate CA; Higuita-Gutiérrez LF; Jiménez-Quiceno JN
    Biomedica; 2019 May; 39(s1):35-49. PubMed ID: 31529847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors and etiology of neonatal sepsis in Tikur Anbessa University Hospital, Ethiopia.
    Shitaye D; Asrat D; Woldeamanuel Y; Worku B
    Ethiop Med J; 2010 Jan; 48(1):11-21. PubMed ID: 20607993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.